EBG00000313325 - n.182C>T
Drug resistance types
5 Sensitive
2 RR-TB
12 HR-TB
3 MDR-TB
1 Pre-XDR-TB
0 XDR-TB
7 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.3.3 | 2 |
| lineage4.3.2.1 | 2 |
| lineage4.9 | 12 |
| La1.7;lineage4.9 | 2 |
| lineage2.2.1 | 4 |
| lineage4.3.4.2.1 | 1 |
| lineage1.2.2.2 | 1 |
| lineage4.8 | 1 |
| lineage3.1.2.1 | 1 |
| lineage4.1.2.1;lineage4.4.1 | 1 |
| lineage4.1.1.3 | 2 |
| lineage2.2.2 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 30 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR12708419 | Other | lineage4.3.3 | None | SRR12708396 | MDR-TB | lineage4.3.2.1 | None | ERR4819051 | Sensitive | lineage4.9 | None | ERR4800644 | HR-TB | lineage4.9 | None | ERR1034634 | HR-TB | lineage4.9 | None | ERR212033 | Other | lineage4.9 | None | ERR212034 | HR-TB | La1.7;lineage4.9 | None | SRR6045010 | Sensitive | lineage4.9 | None | SRR12708414 | HR-TB | lineage2.2.1 | None | SRR12708399 | MDR-TB | lineage4.3.4.2.1 | None | SRR12708418 | HR-TB | lineage2.2.1 | None | SRR12708407 | HR-TB | lineage4.3.2.1 | None | SRR5341330 | Other | lineage4.9 | None | SRR12708411 | HR-TB | lineage1.2.2.2 | None | ERR4813263 | MDR-TB | lineage4.8 | None | ERR4800102 | Sensitive | lineage3.1.2.1 | None | ERR4818110 | Sensitive | lineage4.9 | None | ERR176560 | HR-TB | La1.7;lineage4.9 | None | SRR1049725 | Other | lineage4.1.2.1;lineage4.4.1 | None | SRR12708409 | HR-TB | lineage4.3.3 | None | ERR502481 | RR-TB | lineage4.9 | None | SRR12708413 | HR-TB | lineage4.1.1.3 | None | SRR12708415 | HR-TB | lineage2.2.1 | None | SRR12708371 | HR-TB | lineage4.1.1.3 | None | ERR1063855 | Other | lineage4.9 | None | ERR161037 | Other | lineage4.9 | None | SRR12708370 | Pre-XDR-TB | lineage2.2.2 | None | SRR12708392 | Other | lineage2.2.1 | None | SRR21677886 | Sensitive | lineage4.9 | None | ERR4819863 | RR-TB | lineage4.9 | None |
|---|
